Expired
Lead Plaintiff Deadline
Sep 28, 2021
Choose your preferred way to stay informed of new case launches and settlement deadlines
the likelihood that tenapanor would be approved by the Food and Drug Administration ("FDA"). Defendants possessed, were in control over, and as a result, knew that the data submitted to support the New Drug Application was insufficient in that it showed a lack of clinical relevance of the drug’s treatment effect, making it foreseeably likely that the FDA would not approve the drug.
In order to be eligible to join the ARDX class action lawsuit, you must have incurred a loss on shares of Ardelyx purchased during the class period listed above.
If you suffered a loss in Ardelyx during the relevant time frame or pursuant to the relevant offering(s), you have until September 28, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP
